A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

Clinical trial NCT04480710 · COMPLETED

Trial details

NCT number: NCT04480710
Sponsor: Hepion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis Fibrosis, Liver NAFLD - Nonalcoholic Fatty Liver Disease

Start date: 2020-06-23
Primary completion: 2021-06-29
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.